Latest filing published 04 Sept 2026 for Krystal Biotech, Inc., €8.0M.
Krish Krishnan discloses dealings in Krystal Biotech, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 4 June 2026 to 4 September 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 4 September 2026 came the latest disclosure, a transaction for €8.0M in Krystal Biotech, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations